Drug Type Microbiota |
Synonyms- |
Target |
Action inhibitors |
Mechanism EHMT2 inhibitors(euchromatic histone lysine methyltransferase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Renal Cell Carcinoma | Preclinical | South Korea | 05 Mar 2026 | |
| Renal Cell Carcinoma | Preclinical | South Korea | 05 Mar 2026 |





